Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidence

B Ragnoli, B Da Re, A Galantino, S Kette… - International Journal of …, 2023 - mdpi.com
Since the first description of COVID-19 infection, among clinical manifestations of the
disease, including fever, dyspnea, cough, and fatigue, it was observed a high incidence of …

Prevention of venous thromboembolism in patients with cancer

SR Guntupalli, D Spinosa, S Wethington, R Eskander… - bmj, 2023 - bmj.com
Venous thromboembolism (VTE) is a major cause of both morbidity and mortality in patients
with cancer. Venous thromboembolism, which includes both deep vein thrombosis and …

Hemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems

DA Tsakiris, E Gavriilaki, I Chanou… - Bone marrow …, 2024 - nature.com
Hematopoietic stem cell transplantation (HCT) represents a curative treatment option for
certain malignant and nonmalignant hematological diseases. Conditioning regimens before …

Pathophysiology and optimal treatment of intracranial branch atheromatous disease

I Deguchi, S Takahashi - Journal of Atherosclerosis and Thrombosis, 2023 - jstage.jst.go.jp
Intracranial branch atheromatous disease (BAD) is a pathological condition characterized by
the occlusion of a relatively large perforating branch (700–800 µm) near the orifice of a …

Anticoagulants for atrial fibrillation: from warfarin and DOACs to the promise of factor XI inhibitors

V Kumar, L Ilkhanoff - Frontiers in Cardiovascular Medicine, 2024 - frontiersin.org
Anticoagulation is the mainstay of stroke prevention in appropriate patients with atrial
fibrillation. Due to advances in pharmacotherapy the anticoagulants used for this purpose …

Limitations in contemporary pharmacological stroke prevention therapies in atrial fibrillation: a descriptive literature review

P Garot, MW Bergmann - Journal of Clinical Medicine, 2023 - mdpi.com
The most common arrhythmia, atrial fibrillation (AF), increases with age and is associated
with a 5-fold increased risk of stroke. Although lifelong oral anticoagulation (OAC) is strongly …

Management of Patients Receiving Anticoagulation Therapy in Dental Practice: A Systematic Review

F Inchingolo, AM Inchingolo, F Piras, L Ferrante… - …, 2024 - pmc.ncbi.nlm.nih.gov
Background: Anticoagulant drugs are a valuable tool for minimizing thrombotic risks in at-
risk patients. The purpose of this study is to conduct a literature review highlighting the …

Anti–intercellular adhesion molecule-1 (ICAM-1) nanoparticles for damaged endothelium to treat venous thromboembolism

P Pazhani, S Arumugam, JP Dharmian… - Journal of Dispersion …, 2024 - Taylor & Francis
Venous thromboembolism (VTE) is a potentially fatal vascular disease that can be
successfully managed to reduce the risk of mortality and impairment. Anticoagulation …

Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation

J Friebel, M Wegner, L Blöbaum, PA Schencke… - International Journal of …, 2024 - mdpi.com
Patients with first-diagnosed atrial fibrillation (FDAF) exhibit major adverse cardiovascular
events (MACEs) during follow-up. Preclinical models have demonstrated that thrombo …

[HTML][HTML] Study on Preparation Process of Anticoagulant BAY2433334

Y Zeng, G Cen, G Zhou, X Zhu, L Huang, X Wang - Molecules, 2024 - mdpi.com
A new process route suitable for the industrial production of BAY2433334 has been
developed in this paper, which avoids the patent limitations of the originator company of …